Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures

por Teng, Yvonne H. F., Quah, Hong Sheng, Suteja, Lisda, Dias, João M. L., Mupo, Annalisa, Bashford-Rogers, Rachael J. M., Vassiliou, George S., Chua, Melvin L. K., Tan, Daniel S. W., Lim, Darren W. T., Iyer, N. Gopalakrishna
Publicado 2021

Correction to: Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures

por Teng, Yvonne H. F., Quah, Hong Sheng, Suteja, Lisda, Dias, João M. L., Mupo, Annalisa, Bashford-Rogers, Rachael J. M., Vassiliou, George S., Chua, Melvin L. K., Tan, Daniel S. W., Lim, Darren W. T., Iyer, N. Gopalakrishna
Publicado 2021

Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy

por Liu, Wai Nam, Fong, Shin Yie, Tan, Wilson Wei Sheng, Tan, Sue Yee, Liu, Min, Cheng, Jia Ying, Lim, Sherlly, Suteja, Lisda, Huang, Edwin Kunxiang, Chan, Jerry Kok Yen, Iyer, Narayanan Gopalakrishna, Yeong, Joe Poh Sheng, Lim, Darren Wan-Teck, Chen, Qingfeng
Publicado 2020

Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model

por Liu, Wai Nam, So, Wing Yan, Harden, Sarah L., Fong, Shin Yie, Wong, Melissa Xin Yu, Tan, Wilson Wei Sheng, Tan, Sue Yee, Ong, Jessica Kai Lin, Rajarethinam, Ravisankar, Liu, Min, Cheng, Jia Ying, Suteja, Lisda, Yeong, Joe Poh Sheng, Iyer, N. Gopalakrishna, Lim, Darren Wan-Teck, Chen, Qingfeng
Publicado 2022

Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis

por Quah, Hong Sheng, Cao, Elaine Yiqun, Suteja, Lisda, Li, Constance H., Leong, Hui Sun, Chong, Fui Teen, Gupta, Shilpi, Arcinas, Camille, Ouyang, John F., Ang, Vivian, Celhar, Teja, Zhao, Yunqian, Tay, Hui Chen, Chan, Jerry, Takahashi, Takeshi, Tan, Daniel S. W., Biswas, Subhra K., Rackham, Owen J. L., Iyer, N. Gopalakrishna
Publicado 2023

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

por Lim, Darren Wan-Teck, Kao, Hsiang-Fong, Suteja, Lisda, Li, Constance H., Quah, Hong Sheng, Tan, Daniel Shao-Weng, Tan, Sze-Huey, Tan, Eng-Huat, Tan, Wan-Ling, Lee, Justina Nadia, Wee, Felicia Yu-Ting, Jain, Amit, Goh, Boon-Cher, Chua, Melvin L. K., Liao, Bin-Chi, Ng, Quan Sing, Hong, Ruey-Long, Ang, Mei-Kim, Yeong, Joe Poh-Sheng, Iyer, N. Gopalakrishna
Publicado 2023

A Randomized Phase 2 Trial of Nivolumab Versus Nivolumab-Ipilimumab Combination in EGFR-Mutant NSCLC

por Lai, Gillianne G.Y., Yeo, Jia Chi, Jain, Amit, Zhou, Siqin, Pang, Mengyuan, Alvarez, Jacob J.S., Sim, Ngak Leng, Tan, Aaron C., Suteja, Lisda, Lim, Tze Wei, Guo, Yu Amanda, Shen, Meixin, Saw, Stephanie P.L., Rohatgi, Neha, Yeong, Joe P.S., Takano, Angela, Lim, Kiat Hon, Gogna, Apoorva, Too, Chow Wei, Da Zhuang, Kun, Tan, Wan Ling, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Wang, Lanying, Toh, Chee Keong, Lim, Wan-Teck, Tam, Wai Leong, Tan, Sze Huey, Skanderup, Anders M.J., Tan, Eng-Huat, Tan, Daniel S.W.
Publicado 2022

Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities

por Chua, Khi Pin, Teng, Yvonne H.F., Tan, Aaron C., Takano, Angela, Alvarez, Jacob J.S., Nahar, Rahul, Rohatgi, Neha, Lai, Gillianne G.Y., Aung, Zaw Win, Yeong, Joe P.S., Lim, Kiat Hon, Naeini, Marjan Mojtabavi, Kassam, Irfahan, Jain, Amit, Tan, Wan Ling, Gogna, Apoorva, Too, Chow Wei, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Anantham, Devanand, Phua, Ghee Chee, Tan, Bien Soo, Lee, Yin Yeng, Wang, Lanying, Teo, Audrey S.M., Khng, Alexis Jiaying, Lim, Ming Jie, Suteja, Lisda, Toh, Chee Keong, Lim, Wan-Teck, Iyer, N. Gopalakrishna, Tam, Wai Leong, Tan, Eng-Huat, Zhai, Weiwei, Hillmer, Axel M., Skanderup, Anders J., Tan, Daniel S.W.
Publicado 2021